Briefing
Immune and Circulating Tumor DNA Profiling After Radiation Treatment for Oligometastatic Non-Small Cell Lung Cancer: Translational Correlatives from a Mature Randomized Phase II Trial
Translational correlative analysis of a randomized phase 2 oligometastatic NSCLC trial (NCT01725165): local consolidative therapy was associated with a lower early-follow-up ctDNA mutation count and VAF than maintenance/observation, and among six patients with serial ctDNA a rise preceded clinical progression by 6.7 months; baseline ctDNA metrics were not associated with outcomes.
- Design: Evidence level 3
- Assay: Not named in the abstract
Int J Radiat Oncol Biol PhysPubMed 31678224DOI 10.1016/j.ijrobp.2019.10.038